State Street’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64M Buy
7,141,094
+911,539
+15% +$7.26M ﹤0.01% 1616
2025
Q4
$37.6M Buy
6,229,555
+988,262
+19% +$5.88M ﹤0.01% 1902
2025
Q3
$29.9M Sell
5,241,293
-13,419
-0.3% -$68.6K ﹤0.01% 2013
2025
Q2
$26.5M Sell
5,254,712
-472,451
-8% -$2.53M ﹤0.01% 2031
2025
Q1
$37.1M Buy
5,727,163
+652,432
+13% +$5.8M ﹤0.01% 1803
2024
Q4
$37.2M Sell
5,074,731
-550,802
-10% -$4.34M ﹤0.01% 1863
2024
Q3
$42.1M Buy
5,625,533
+530,645
+10% +$4.61M ﹤0.01% 1785
2024
Q2
$45.3M Sell
5,094,888
-1,972,733
-28% -$18.9M ﹤0.01% 1724
2024
Q1
$71.6M Buy
7,067,621
+155,539
+2% +$1.58M ﹤0.01% 1520
2023
Q4
$69.5M Sell
6,912,082
-261,346
-4% -$2.39M ﹤0.01% 1517
2023
Q3
$67.2M Buy
7,173,428
+1,754,624
+32% +$25M ﹤0.01% 1428
2023
Q2
$133M Buy
5,418,804
+34,641
+0.6% +$870K 0.01% 1035
2023
Q1
$125M Sell
5,384,163
-92,294
-2% -$2.36M 0.01% 1040
2022
Q4
$139M Sell
5,476,457
-353,960
-6% -$8.68M 0.01% 955
2022
Q3
$112M Buy
5,830,417
+311,279
+6% +$7.91M 0.01% 1041
2022
Q2
$141M Buy
5,519,138
+1,325,374
+32% +$30.9M 0.01% 948
2022
Q1
$108M Buy
4,193,764
+1,665,657
+66% +$49.4M 0.01% 1240
2021
Q4
$106M Buy
2,528,107
+240,241
+11% +$9.41M 0.01% 1260
2021
Q3
$99.6M Buy
2,287,866
+135,931
+6% +$5.89M 0.01% 1263
2021
Q2
$102M Buy
2,151,935
+273,208
+15% +$12.4M 0.01% 1274
2021
Q1
$96.3M Sell
1,878,727
-1,056,977
-36% -$57M 0.01% 1264
2020
Q4
$78.6M Buy
2,935,704
+2,006,874
+216% +$65.2M ﹤0.01% 1337
2020
Q3
$31.9M Buy
928,830
+93,486
+11% +$4.02M ﹤0.01% 1757
2020
Q2
$34.2M Buy
835,344
+708,966
+561% +$23.8M ﹤0.01% 1690
2020
Q1
$4.33M Buy
126,378
+85,618
+210% +$2.3M ﹤0.01% 2702
2019
Q4
$513K Buy
+40,760
New +$546K ﹤0.01% 3520

Other funds holding VIR